BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2059513)

  • 1. [Hepatic activity of glutathione transferase and bromsulphalein metabolism].
    Serra MA; Caballero A; Aparisi L; Rodrigo JM; Del Olmo JA; Ferrando J; Wassel AH; Reig G; Bixquert M
    Rev Esp Enferm Dig; 1991 Feb; 79(2):112-6. PubMed ID: 2059513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.
    Häcki W; Bircher J; Preisig R
    J Lab Clin Med; 1976 Dec; 88(6):1019-31. PubMed ID: 993641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
    Zhao Y; Snel CA; Mulder GJ; Pang KS
    Drug Metab Dispos; 1993; 21(6):1070-8. PubMed ID: 7905386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine effects on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    J Pharmacol Exp Ther; 1985 Nov; 235(2):393-7. PubMed ID: 4057076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximal biliary transport of sulfobromophthalein in patients with a T-tube placed in the common bile duct.
    Serra MA; Caballero A; Del Olmo JA; Aparisi L; Gilabert MS; Rodríguez F; Escudero A; Wassel A; Ferrando J; Reig G; Rodrigo JM
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):135-9. PubMed ID: 9248781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolism of sulfobromophthalein in jaundiced rat].
    Ishii K; Fuse M; Mizuyoshi H; Yamamuro W
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1423-9. PubMed ID: 2214267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-dependent effects of acute submaximal exercise on the pharmacokinetics of bromsulphalein in horses.
    Dyke TM; Sams RA; Hinchcliff KW
    Am J Vet Res; 1998 Nov; 59(11):1481-7. PubMed ID: 9829411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood cholinesterase and hepatic function: a comparison with BSP and galactose elimination as well as serum albumin concentration].
    Gross O; Audetat V; Bircher J
    Schweiz Med Wochenschr; 1978 Sep; 108(36):1389-93. PubMed ID: 705294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interpretation of bromsulphalein (BSP) value in liver diseases--with special reference to the analytical result of BSP metabolism].
    Ito K; Nakagawa J; Nakano H; Tamai Y; Maeda K
    Nihon Rinsho; 1967 Aug; 25(8):1917-25. PubMed ID: 5627398
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex differences in sulfobromophthalein-glutathione transport by perfused rat liver.
    Sorrentino D; Licko V; Weisiger RA
    Biochem Pharmacol; 1988 Aug; 37(16):3119-26. PubMed ID: 3401243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of hepatobiliary diseases by the evaluation of bromsulfophthalein blood kinetics.
    Molino G; Milanese M; Villa A; Cavanna A; Gaidano GP
    J Lab Clin Med; 1978 Mar; 91(3):396-408. PubMed ID: 627746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats.
    Foliot A; Touchard D; Celier C
    Biochem Pharmacol; 1984 Sep; 33(18):2829-34. PubMed ID: 6477642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cage bedding on the metabolism of sulphobromophthalein sodium by an hepatic cytosol-located enzyme system.
    Whelan G
    Aust J Biol Sci; 1975 Feb; 28(1):25-9. PubMed ID: 1164255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
    Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
    Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolated pathology of BSP excretion. Study of 4 patients].
    de Groote J; Ramboer C; Versieck J; Barbier F
    Rev Int Hepatol; 1968; 18(6):833-44. PubMed ID: 5702104
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic function test--2. Bilirubin metabolism, bromsulphalein (BSP) excretion test.
    Goldston RT; Wilkes RD; Seybold IM
    Vet Med Small Anim Clin; 1981 Jun; 76(6):795-7. PubMed ID: 6911907
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics.
    Kolobe D; Sayed Y; Dirr HW
    Biochem J; 2004 Sep; 382(Pt 2):703-9. PubMed ID: 15147239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of bromosulphthalein from plasma as a measure of hepatic function in normal horses and in horses with liver disease.
    West HJ
    Res Vet Sci; 1988 May; 44(3):343-8. PubMed ID: 3406531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What does the BSP retention measure? Comparison of BSP-transport maximum, storage capacity and capacity for elimination of galactose].
    Imesch B; Häcki W; Bircher J
    Schweiz Med Wochenschr; 1973 Mar; 103(11):397-403. PubMed ID: 4691799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.